Clinical investigation for infections caused by Enterobacteriaceae in intensive care unit of Anhui, China  by Sun, Jing et al.
www.elsevier.com/locate/bjid
The Brazilian Journal of
INFECTIOUS DISEASES
BRAZ J INFECT DIS. 2012;16(1):109-110
Dear Editor,
Enterobacteriaceae has emerged as the most common 
isolates of Gram-negative bacilli.1 Antibiotic resistance 
surveillance programs have demonstrated an increase in 
resistance among these pathogens.2 The problem of resistance 
is of particular concern in the intensive care unit (ICU) setting.
One hundred and nine ICU patients from whom Escherichia 
coli, Klebsiella pneumoniae, and Enterobacter cloacae were isolated 
between March 1, 2003 and December 30, 2009 were included. 
The mean age of the patients was 59.51 ± 18.33 years (range 
7-102 years) and 86 (66.1%) patients were male. The mean 
length of stay in the hospital was 47.18 ± 59.44 days (range 
1-426 days). Fever (range 37.6-41.0°C) occurred in 37 of 109 
patients. White blood cell counts were 14.14 ± 8.50 (×109/L). The 
common underlying conditions were biliary disease (30.3%), 
cardiovascular disease (21.1%), lung disease (18.3%), and 
diabetes (10.1%). Of the total, 93 (85.3%) patients underwent 
surgical interventions.
The isolates obtained from different samples per patient 
were identified using the Microscan Walkaway-40 system 
(Dade Behring – USA) and the antimicrobial susceptibility 
tests were also performed with this system. Antimicrobial 
susceptibility was interpreted according to criteria of the 
Clinical and Laboratory Standards Institute (CLSI).3 A total of 
154 isolates including E. coli (66.2%), K. pneumoniae (20.8 %), 
and E. cloacae (13.0%) were available for investigation from 
109 patients. The top-five samples were isolated from sputum 
(25.3%), pus (20.8%), bile (16.9%), peritoneal fluid (10.4%), and 
blood cultures (5.8%). The results of antimicrobial susceptibility 
test of different strains are listed in Table 1. Imipenem was 
consistently the most active antibiotic among those tested. 
The overall multiresistance rate (a multiresistant strain 
was defined as in vitro resistance to at least three classes of 
cephalosporins, quinolones, aminoglycosides, and β-lactams) 
was 67.8% (74/109). Of 109 patients, 86.2% (94/109) received an 
empirical antibiotic therapy and 43.1% patients were treated 
with at the least two types of the four antibiotics listed above. 
Multiresistance was significantly associated with empirical 
antibiotic therapy with cephalosporins (χ2 = 5.777, p = 0.016) 
and quinolones (χ2 = 4.089, p = 0.043) in a multivariate analysis.
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Antibiotic E. coli (n = 102) K. pneumoniae (n = 32) E. cloacae (n = 20)
 n R% n R% n R%
Imipenem 3 2.9 3 9.4 2 10
Ampicillin 34 33.3 15 46.9 20 100
SMZ-TMP 74 72.5 20 62.5 16 80
Cefepime 22 21.5 8 25 18 90
Ceftazidime 46 45.1 11 34.4 17 85
Cefatriaxone 63 61.8 16 50 18 90
Cefotaxime 50 49 12 37.5 18 90
Cefoxitin 13 12.7 11 34.4 18 90
Amikacin 22 21.6 11 34.4 12 60
Aztreonam 56 54.9 13 40.6 19 95
Gentamicin 61 59.8 17 53.1 12 60
Tobramycin 72 70.6 13 40.6 17 85
Ciprofloxacin 75 73.5 16 50.0 17 85
Ampicillin/sulbactam 85 83.3 18 56.3 20 100
Table 1 - Antimicrobial resistance of Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae
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Among 109 patients, 69 patients used mechanical 
ventilators, and 25 patients had a positive sputum culture and 
imaging. Only 21 patients fulfilled the definition of ventilator-
associated pneumonia (VAP).4 Diagnosis of pneumonia 
was significantly associated with the use of ventilators by 
univariate analysis (χ2 = 5.982, p = 0.014). 20.2% (23/109) of 
the investigated patients died. Firstly, we reported the risk 
factors associated with the mortality by univariate analysis. 
When these factors were further subjected to multivariate 
analysis, comorbidity (χ2 = 5.609, p = 0.018), catheterization, 
venous peripheral catheter, and ventral intubation (χ2 = 6.829, 
p = 0.009; χ2 = 10.031, p = 0.002; χ2 = 7.968, p = 0.005) were 
found to be significantly associated with mortality. However, 
no significant association was found between the use of 
ventilators and mortality. 
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